Skip to main content
. 2012 Aug 27;7:76. doi: 10.1186/1749-8090-7-76

Table 1.

Patients characteristics, LOS and endpoints

 
  
  
 Pre-LVAD phase days)
 LVAD phase (days)
 Total in-hospital stay (days)
 End point
  Patient # Age (years) Sex LOS ECMO LOS LOS LOS ICU LOS
VA 1
 64
 M
 20
  
 22
 25
 42
 Htx
VA 2
 62
 M
 1
  
 26
 7
 27
 †
VA 3
 15
 F
 8
  
 26
 6
 34
 Htx
VA 4
 38
 M
 5
 6
 28
 27
 33
 Htx
VA 5
 23
 M
 8
  
 32
 10
 40
 Htx
VA 6
 54
 M
 1
 14
 26
 18
 27
 Htx †
VA 7
 65
 M
 8
  
 29
 11
 37
 *
VA 8
 16
 F
 15
 23
 42
 13
 57
 *
VA 9
 20
 M
 13
  
 21
 5
 34
 Htx
VA 10
 59
 M
 14
  
 88
 35
 102
 †
VA 11
 55
 M
 8
  
 39
 39
 47
 †
VA 12
 53
 F
 12
  
 32
 21
 44
 Htx
VA 13
 10
 M
 6
  
 39
 14
 45
 Htx
VA 14
 19
 M
 49
  
 42
 17
 91
 Htx
VA 15
 27
 M
 39
 11
 56
 18
 95
 Htx
VA 16
 29
 M
 2
  
 125
 56
 127
 Htx
VA 17
 32
 M
 32
  
 45
 23
 77
 Htx
VA 18
 21
 M
 44
  
 25
 14
 69
 Htx
VA 19
 61
 M
 1
  
 40
 12
 41
 Htx
VA 20
 16
 M
 8
 4
 4
 12
 12
 Htx
HW 1
 39
 M
 0
 3
 41
 15
 41
 Htx
HW 2
 72
 M
 5
  
 42
 21
 47
 Htx
HW 3
 56
 M
 29
  
 29
 8
 58
 *
HW 4
 62
 F
 11
  
 31
 12
 42
 †
HW 5
 54
 M
 36
  
 57
 40
 93
 Htx
HW 7
 61
 M
 6
 7
 27
 9
 33
 Htx
HW 8
 26
 M
 12
  
 19
 7
 31
 Htx
HW 10
 35
 M
 17
  
 40
 6
 57
 Htx
HW 11
 46
 M
 6
  
 30
 13
 36
 Htx
Mean
 41
  
 14
 10
 38
 18
 52
  
Range (10-72)   (1-49) (3-23) (4-125) (5-56) (12-127)  

VA VentrAssist™LVAD.

HW HeartWare™LVAD.

M Male.

F Female.

LOS (Length of Stay) in days.

ECMO Extra Corporeal Membrane Oxygenation.

ICU Intensive Care Unit.

Htx Heart transplantation.

End points: † = dead, * = on device.

^^ patient no 6 and 9 from the HeartWare LVAD study was excluded as patient had HW BIVAD.

**Mean cost for ECMO is only for the patients with ECMO.